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1. Introduction
Women have played an important role in highlighting the issues around the misuse of  
illegal drugs in this country. During the 1990s in Dublin’s disadvantaged inner city areas 
women organised direct action campaigns and anti-drug marches, which prompted 
government action to tackle the drugs problem (Murphy-Lawless, 2002). Although women 
were the ones to take action on the area, at a societal level, drug misuse is a larger problem 
among men than women. A detailed look at the issue reveals a more complicated picture, 
however, in which the prevalence of drug use and related health and social consequences 
diﬀer greatly between the sexes. In addition, changing patterns of drug misuse among 
young people mean that drug misuse may be becoming a larger problem for women than  
it has been traditionally. 
The Women’s Health Council, in line with its statutory instrument, has focused on the area 
of women and drug misuse in order to investigate current trends, examine the particular 
circumstances that lead to and result from drug misuse among women, and draw out the 
particular eﬀects of drug misuse on women’s health and well-being. The paper will examine 
the misuse of both legal and illicit drugs. The Council envisages that it will be of interest to 
policy and strategy makers, as well as health service providers and those with an interest in 
women’s health.
The Women’s Health Council
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Data on drug misuse in Ireland is gathered by a number of organisations. The National 
Advisory Committee on Drugs (NACD), established in July 2000 under the auspices of the 
Department of Tourism, Sport and Recreation, has conducted two general population 
surveys of drug misuse to date. It found that in 2006/7, 24% of people aged 15 to 64 years in 
this country reported taking illegal drugs during their lifetime. This represented an increase 
from 19% in 2002/3 (NACD & DAIRU, 2008b). Similarly, the proportion of young adults (15-34 
years) reporting illegal drug use in their lifetimes increased from 26% in 2002/3 to 31% in 
2006/7 (NACD & DAIRU, 2008b). Those in the younger age groups were more likely to misuse 
drugs, with lifetime use highest in those aged 25-34 years (34%), although last year and 
last month use was highest for those aged 15-24 years (15% and 6% respectively) (NACD & 
DAIRU, 2008b). 
The Alcohol and Drug Research Unit (ADRU) of the Health Research Board (HRB) maintains 
two national drug-related surveillance systems, focusing on drug and alcohol treatment 
data. Research recently published by the ADRU found that the prevalence of treated 
problem drug use among 15–64-year-olds living in Ireland increased by 15% between 2001 
and 2006, from 372 per 100,000 of the population in 2001 to 426 in 2006 (Reynolds et al., 
2008). However, the number of new cases entering treatment was found to be marginally 
lower in 2006 (74.8 cases per 100,000) than in 2001 (75.7 cases) (Reynolds et al., 2008). 
2.1. Women compared with men
As stated in the introduction, drug use globally is an overwhelmingly male activity 
(EMCDDA, 2006). The ‘typical’ problem drug user proﬁled in the research is young and male, 
unemployed, with no stable home and a low level of education (Reynolds et al., 2008). 
General population data have shown that men are more likely to misuse drugs than women, 
with 29% of men reporting lifetime use of any illegal drugs compared to 19% of women 
(NACD & DAIRU, 2008b), and research on young people has shown that male students were 
much more likely to use illegal drugs than female students (Hope et al., 2005). The European 
Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has noted, however, that the 
ratio of women misusing drugs compared to men increases as overall prevalence of drug 
use increases, although it is usually lower for the more illegal drugs and for recent or frequent 
patterns of drug misuse (EMCDDA, 2005).
Men also outnumber women among those attending services for the treatment of drug 
misuse; overall in Europe, women only make up 20% of the population availing of services 
(EMCDDA, 2005). However, research has shown that women experience particular barriers to 
accessing services (discussed in section 5.3) that hamper their participation; it may therefore 
be that women are underrepresented in the treatment population and there may be 
considerable unmet need in the area. Although men are more likely to misuse illegal drugs 
than women, for prescription drugs, such as tranquillisers and anti-depressants, women have 
2. Prevalence
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been found to predominate (NACD & PHIRB, 2009). This may imply that women’s pathways 
to drug misuse are diﬀerent to men’s, or that they misuse drugs for diﬀerent reasons. It may 
also mean that women have diﬀerent experiences of drug use to men, and therefore also 
diﬀerent health and social consequences around drug use. For example, research has  
shown that women who misuse drugs are more likely to engage in higher risk practices, 
such as injecting drugs, than their male counterparts, which would leave them open to a 
greater range of health risks especially if they share injecting equipment (EMCDDA, 2005, 
O’Brien & Dillon, 2001).
2.2. Converging patterns among young people
While traditionally more males than females misuse drugs, there have been indications in 
recent research that the gap in illicit drug use is narrowing among those in the younger age 
groups. EMCDDA ﬁgures for Ireland have shown that among school students, an equal ratio 
of 15-16 year old boys and girls have ever used cannabis, and, although more adult males 
than females have ever taken ecstasy, a slightly larger ratio of 15-16 year old girls than boys 
have repeatedly used the drug (EMCDDA, 2006). An Irish study of adolescent opiate use 
found that whereas during the 1990s males were more at risk of opiate misuse, now male 
and female teenagers are equally at risk (Fagan et al., 2008). These ﬁgures, which mirror the 
situation in the rest of Europe, would seem to suggest that the traditional gender gap in 
drug misuse is closing among younger people and it has signiﬁcant implications for the 
future. If young women persist in using drugs in a similar manner to their male counterparts, 
it is likely that there will be an overall increase in the prevalence of drug misuse in the future, 
with knock on eﬀects for treatment and rehabilitation services. 
2.3. Types of drugs
Overall, cannabis is the most commonly misused drug in Ireland, followed by magic 
mushrooms, ecstasy, cocaine and amphetamines (NACD & PHIRB, 2008a, Hope et al., 2005). 
Among those in treatment for drug misuse, cannabis was the most common problem  
drug, followed by opiates and cocaine (Reynolds et al., 2008). Polydrug use (using more  
than one substance) has been identiﬁed as a growing problem, involved in 70% of cases 
entering or returning to treatment in 2005 (Department of Community Rural and Gaeltacht 
Aﬀairs, 2007).
These population ﬁgures can mask important diﬀerences in patterns of drug misuse 
between men and women, however. While men predominantly use cannabis, opiates 
and cocaine, women are more likely to misuse stimulants and pharmaceutical drugs such 
as tranquillisers/sedatives and anti-depressants (EMCDDA, 2005, EMCDDA, 2006, NACD & 
PHIRB, 2009). In 2005, for example, a study of Irish students found that while 45.4% of male 
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students had used cannabis compared to 32.4% of females, equal proportions of both 
had misused tranquillisers (1.3%) (Hope et al., 2005). Figures from the HRB’s National Drug 
Treatment Reporting System (NDTRS) showed that diﬀerences in the numbers of men and 
women treated for use of volatile inhalants and benzodiazepines were less pronounced than 
those for other drugs such as cocaine, cannabis and amphetamines (Reynolds et al., 2008). 
Most recently, ﬁgures published by the NACD indicated that women actually have higher 
prevalence rates for lifetime use of sedatives/tranquillisers and anti-depressants than men 
(NACD & PHIRB, 2009). Figures for the main types of drugs misused are examined in more 
detail below.
2.2.1. Cannabis
Cannabis is the most commonly used illegal drug in Ireland. The proportion of adults who 
reported using cannabis at some point in their life increased from 17% in 2002/3 to 22% 
in 2006/7 (NACD & DAIRU, 2008b). A higher proportion of men report using cannabis 
than women - 27% of men compared to 17% of women (NACD & DAIRU, 2008b). Among 
students, 22% of males said they had used cannabis ten or more times in the past year 
compared to 11% of females (Hope et al., 2005). However, as noted above, more recent 
ﬁgures have shown that among school students in Ireland, an equal ratio of 15-16 year old 
boys and girls reported ever having used cannabis (EMCDDA, 2006).
2.2.2. Ecstasy
The NACD population survey in 2006/7 found that just over 5% of adults reported taking 
ecstasy at least once in their lifetime. Within this ﬁgure, twice as many men reported using 
ecstasy than women (NACD & DAIRU, 2008b). This reﬂects the pattern in the rest of Europe, 
but again, as mentioned above, in Ireland among school students a slightly larger ratio of 
15-16 year old girls than boys reported repeatedly using the drug (40+ times during their 
lifetime) (EMCDDA, 2006). 
2.2.3. Cocaine
Misuse of cocaine has increased in Ireland in recent years, with the proportion of adults who 
reported using cocaine (including crack) at some point in their life increasing from 3% in 
2002/3 to 5% in 2006/7, while among those aged 15 – 34 years the proportion increased 
from 5% in 2002/3 to 8% in 2006/7 (NACD & PHIRB, 2008c). In line with this increase, the 
number of new cases in treatment who reported cocaine as their main problem drug 
also increased signiﬁcantly, from 43 in 2001 to 342 in 2006 (Reynolds et al., 2008). Cocaine 
consignments in Ireland have also been found to have increased signiﬁcantly (International 
Narcotics Control Board, 2008). 
The most recent population survey found that in Ireland lifetime prevalence rate for cocaine 
powder and/or crack among men is twice that of women (7% compared to 3%). Compared 
to the previous survey carried out in 2003/4, these rates represented a signiﬁcant increase 
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– the lifetime prevalence rate for any type of cocaine use among women was previously 
1.6%. The average age at ﬁrst use of cocaine powder was 21 for women, compared to 22 for 
men (NACD & PHIRB, 2008c, NACD & DAIRU, 2008a).
2.2.4. Opiates
Opiates, particularly heroin, have been in heavy use among drug misusers in Ireland for 
more than thirty years. Their use is especially associated with Dublin’s disadvantaged inner 
city areas, where the ‘opiate epidemic’ is said to have peaked in the years between 1979 and 
1983 (Dean et al., 1987), although Ireland still has a high prevalence of young opiate misusers 
compared to other European countries (Fagan et al., 2008). It was estimated that there were 
14,452 opiate users aged 15-64 in Ireland in 2001 (Kelly et al., 2004). During the same time 
period, researchers found a statistically signiﬁcant increase in the number of young women 
aged 25-34 using opiates. This trend seems to have continued, with reports of a greater 
number of female teenagers attending the Trinity Court Drug Treatment Centre for heroin 
misuse in 2005 (17 out of 19 teenagers were female) (Ring, 2005), and women being more 
likely than men to report use of “other opiates”1 (8% compared with 5%) in the latest NACD 
prevalence study (NACD & DAIRU, 2008b). Figures from the NACD show clearly that women 
are now more likely to misuse opiates than men; they found that female lifetime, last year 
and last month prevalence rates for other opiates were at least double those of males  
(NACD & PHIRB, 2008a). The EMCDDA, in its most recent Annual Report, highlighted the 
fact that opioid drugs, mainly heroin, are the drugs most often associated with overdose 
(EMCDDA, 2008a).
2.2.5. Prescription drugs
The International Narcotics Control Board has stated that as the use of prescription drugs, 
such as sedatives or anti-depressants, has increased, so too has the misuse of these drugs, 
to the point that internationally prescription drugs are now the second most misused class 
of drugs after cannabis (Zarocostas, 2007). This issue is of particular concern for women as, 
although men outnumber women for use of most categories of illicit drugs, women have 
been found to predominate where prescription drugs are concerned. 
Research carried out by the Women’s Health Council in Ireland found that women were 
more likely than men to be taking prescription medicine, and that in the population 
overall, women in least well oﬀ socio-economic groups were the most likely to be taking 
prescription medication (Women’s Health Council, 2008). In more speciﬁc research, women 
in Ireland report higher prevalence rates for lifetime use of sedatives or tranquillisers than 
men (13% compared to 8%), and also anti-depressants (13% compared to 6%) (NACD & 
DAIRU, 2008b, NACD & PHIRB, 2009). Research carried out by the Department of Health & 
Children’s Benzodiazepine Committee found that use of benzodiazepines increased with 
1   The category ‘other opiates’ included Opium, Temgesic®, Diconal®, Napps, MSTs®, Pethidine, Dihydrocodeine, Buprenorphine, 
Morphine, Codeine, Kapake, Diﬀs, Dikes, Peach, Fentanyl, and Oxycodone.
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age, reaching a peak in the late 60s and early 70s, with higher usage being found amongst 
females of all age groups (Department of Health & Children, 2002). It has been suggested 
that for some older women increasing physical ailments such as arthritis bring them into 
contact with prescription drugs which may be misused if not appropriately prescribed and 
monitored (The National Center on Addiction & Substance Abuse at Colombia University, 
2006). In addition, the depression and anxiety that can accompany physical ailments may 
increase the risk that older women will misuse prescription drugs to alleviate their distress.
The higher rate at which women are prescribed tranquillisers, sedatives and anti-depressants 
when compared to men is a serious cause for concern. The Benzodiazepine Committee 
found that prescribing rates for males in 1999 and 2000 were 10.6% and 7.4% respectively, 
compared to 15.8% and 11.8% for females (Department of Health & Children, 2002). A 
community-based research project carried out in Ballymun in Dublin found that two-thirds 
of the benzodiazepines dispensed by community pharmacies in the area went to women 
(Ballymun Youth Action Project, 2004), with most believing that doctors prescribed the drugs 
‘to help women cope’. Worryingly, it has been found that women are twice as likely as men 
to have benzodiazepines prescribed to them for ‘non-clinical’ symptoms such as stress, grief, 
acute or chronic illness, physical pain or adjustment to a major life change and to have them 
prescribed for longer periods (Cormier et al., 2004, Ballymun Youth Action Project, 2004, 
Poole & Dell, 2005). The NACD also found associations between higher prevalence rates of 
tranquilliser and anti-depressant use and indicators of deprivation such as not being in paid 
work, lower levels of educational attainment, and long term dependence on state beneﬁts 
(NACD & PHIRB, 2009). The WHC has previously shown that women are more likely than 
men to be represented in these categories (Women’s Health Council, 2003, Women’s Health 
Council, 2001, Women’s Health Council, 2007).
Long term benzodiazepine use can lead to dependence, and research carried out in Canada 
found that women are more likely to become chronic users than men (Kermode-Scott, 
2007). Although only small numbers of individuals currently present for treatment for 
problem benzodiazepine or other prescription drug use, the HRB has recommended that 
the impact of these drugs must be addressed within treatment and prevention services 
(Lyons et al., 2008). Given the higher prevalence rates among women, it is essential that such 
treatment services pay particular attention to women’s needs and that women are targeted 
by any health promotion or prevention campaigns undertaken in this regard.  
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2.2.6. Polysubstance use
Recent ﬁgures have shown that in most cases where drug use is an issue, several substances 
are being used simultaneously (polysubstance use). For example, the majority of deaths 
directly due to drugs on the HRB’s National Drug Related Deaths Index (NDRDI) showed 
polysubstance use, and the majority of people entering treatment for the ﬁrst time between 
2001 and 2006 reported problem use of more than one drug (Reynolds et al., 2008, Lyons 
et al., 2008). Overall, among new treatment cases between 2001 and 2006, 31% reported 
use of two substances, 23% reported using three substances simultaneously and 18% 
reported problem use of four or more substances (Reynolds et al., 2008). In Ireland, the 
NACD population drug survey of 2002/2003 found that polysubstance use (most commonly 
combining use of alcohol, tobacco and any illegal drug) was more common among men 
(2.65%) than women (1.2%) (NACD & DAIRU, 2007)2.
Polysubstance use is problematic for a number of reasons, not least that it increases a 
person’s risk of death or serious harm to health. It also increases the complexity of an 
individual’s problems and needs, and it is associated with poorer treatment outcomes. As 
polysubstance use appears to be rising in Ireland, commentators have emphasised the need 
for treatment services that work in an integrated and ﬂexible manner to manage all of the 
drug user’s needs, addressing both alcohol and drug use at the same time. 
2  Results from the 2006/7 survey on this variable have not yet been published.
The Women’s Health Council
10
  ‘Men and women characteristically have diﬀerent histories of drug use, from initiation to exit. 
The reasons for those diﬀerences are complex and are related to a mix of social, physiological 
and personal factors (EMCDDA, 2006).
When examining the issue of drug misuse among women, it is important to acknowledge 
that women are not a homogeneous population – they come from diverse backgrounds, 
with diﬀerent socio-economic circumstances, ethnicities, religions, ages, and family 
backgrounds (Poole & Dell, 2005). These charactaristics can all aﬀect their likelihood of 
misusing drugs. When comparing women to men, it is essential to note the importance of 
the social network for women, as researchers have pointed out that initiation into drug use 
is rarely due to the intervention of a drug-pushing stranger; it usually happens in a familiar 
context with friends, relatives or neighbours playing an important role (Connolly, 2005). 
Regarding motivation to misuse drugs, the U.S. National Center on Addiction and Substance 
Use has stated that girls and women tend to use drugs (including tobacco and alcohol) to 
improve mood, increase conﬁdence, reduce tension, cope with problems, lose inhibitions, 
enhance sex or lose weight. Given their diﬀerent misuse and motivating patterns, women’s 
treatment needs may therefore also be quite diﬀerent to men’s, with an increased emphasis 
on care and support as emotional and relational reasons are often at the crux of women’s 
misuse of drugs (Poole & Dell, 2005, National Center on Addiction & Substance Abuse, 2003).
3.1. Family background
Lack of cohesive and supportive family life seems to be one of the most signiﬁcant 
predisposing factors to drug use among women. A report published by the British Home 
Oﬃce found that parental discipline, family cohesion and parental monitoring were key 
predictors of drug use, and large family size and low parental age were also linked to 
adolescent drug misuse (Frisher et al., 2007). A study of a sample of Irish drug users published 
in 1980 found that the cohort was characterised by a high level of familial problems, such as 
separation from parent before the age of 16, poor parental relationship, paternal alcoholism, 
maternal psychiatric disorder, vague or erratic disciplinary code, or the death of a parent 
before the individual was 16 (Carr et al., 1980). Similar ﬁndings were made in a more recent 
study of young opiate users, which found that many came from a ‘dysfunctional’ family, with 
52% having childhood involvement with social services (Fagan et al., 2008). A family history 
of substance misuse was also found to be common. Irish research on pregnant opiate users 
found that these women tended to have poor family relationships, or come from families 
with a history of alcohol misuse, drug abuse and/or psychological problems (Farrell, 2001). 
It has been suggested that girls are more responsive than boys to parental inﬂuences on 
substance use; Irish research has found that parental disapproval and ‘bonding’ to family 
(particularly to parents) tend to act as restraining factors in substance use (Grube & Morgan, 
1990). In addition, American research has found that the worse a girl’s relationship with her 
3. Factors Associated with Drug Misuse
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parents, the earlier she will begin drinking alcohol and the greater her likelihood of misusing 
drugs (The National Center on Addiction & Substance Abuse at Colombia University, 2006).
3.2. Drug misusing partner
Internationally, research has found that a woman’s partner has an important inﬂuence on  
her drug use. Women are more likely than men to have been introduced to drugs by a 
partner, and overall, women who misuse drugs are far more likely to be living with a drug 
misusing partner than are their male counterparts (Farrell, 2001, Dorman et al., 1997, Woods, 
1994, O’Neill & O’Connor, 1999, Fagan et al., 2008, UNODC, 2004). Some researchers went 
so far as to say that it was ‘extremely rare’ to ﬁnd a drug-using woman living with a non-
drug using man, even though many drug using men live with women who do not use 
drugs (Woods, 1994). Most recently, Fagan et al (2008) found that a large proportion of 
the young female opiate users they studied were in relationships with older male heroin 
users. Women in a long-term relationship with a drug user may lack the partner support 
which is an important factor in presenting to and remaining in treatment (Hedrich, 2000), 
and the relationship may also create diﬃculties around recovery and living in a drug-free 
environment. It is therefore a signiﬁcant concern regarding the challenges it can pose for 
women’s treatment and rehabilitation.
3.3. Age
Illicit drug misuse is generally more common among younger people – those in the 15-
24 year age group are more likely to report last year and last month use of illicit drugs 
than those in other categories, for example (NACD & DAIRU, 2008b). Internationally, it has 
been found that women tend to start misusing drugs at a slightly later age than their male 
counterparts (Hser et al., 1987). In Ireland, however, women have been found to have a 
slightly lower average age than men for starting to use cocaine (21 for women compared 
to 22 for men) (NACD & PHIRB, 2008c), and the average age at which both males and 
females started using cannabis was 18 years (NACD & PHIRB, 2008b). Regarding treatment, 
international data have shown that the highest proportions of females in drug treatment 
are under 20 years and over 39 years (EMCDDA, 2005). The types of drugs for which women 
are being treated diﬀers according to age; those under 20 are most likely to be misusing 
amphetamine-type stimulant drugs, while those in the older age groups are more likely to 
misuse sedatives or prescription drugs. This suggests a pattern of recreational use of illicit 
drugs during youth, with a heavier reliance on prescription drugs among older women. 
In Ireland, women tend to present for drug treatment at a younger age than their male 
counterparts (Geoghegan et al., 1999, O’Brien & Dillon, 2001).
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3.4. Education & socio-economic status 
Early school leaving is a common pattern among drug users, both male and female, and 
perhaps as a result, unemployment is also the norm. A recent Irish study of 86 adolescent 
opiate users in treatment found that early school leaving was common, and 57% reported 
that they had never been in employment after leaving school (Fagan et al., 2008). An earlier 
study of Irish drug users revealed similar ﬁndings; the average age for school leaving among 
those studied was 16 and 63% were unemployed at the time of the study. Recently, the 
Health Research Board has found that rates of employment are highest among those in 
treatment for use of ‘recreational’ drugs like ecstasy, cocaine and amphetamines, while those 
who used drugs such as opiates and benzodiazepines had the lowest rates of employment 
(Reynolds et al., 2008). 
Research has shown that women who misuse drugs often have higher educational levels 
than their male counterparts (EMCDDA, 2005), perhaps because they are on average 
older when they start to use drugs. Women are less likely than their male counterparts 
to be employed in the labour market, however, which could be explained by the higher 
proportion of female drug users who live with and care for children. Looking at those in 
treatment for drug misuse, the EMCDDA has found that a higher proportion of women are 
economically ‘inactive’ and that unemployment rates are more than 10% higher among 
women than among male drug users in treatment (EMCDDA, 2006). This is a signiﬁcant 
ﬁnding, as research has shown that being employed seems to have a protective eﬀect to 
some degree; it has been found that drug users in employment use their main problem  
drug less frequently and report better treatment outcomes than their unemployed 
counterparts (Keane, 2007).
3.5. Violence & sexual abuse
For women, drug misuse seems to be strongly linked with having experience of violence 
and/or sexual abuse. Research has shown that a large proportion of women with substance 
use problems are victims of domestic violence, incest, rape, sexual assault and child physical 
abuse (Cormier et al., 2004, Roberts & Vromen, 2005, Woods, 1999, UNODC, 2004). The 
National Center on Addiction & Substance Abuse at Colombia University has found that girls 
who report having experienced physical or sexual abuse are twice as likely to smoke, drink or 
use drugs as those who were not abused (National Center on Addiction & Substance Abuse, 
2006, National Center on Addiction & Substance Abuse, 2003). One explanation for the 
higher levels of drug use among women who have been abused is that drugs may be used 
as a way of coping with the pain, both physical and mental, of such experiences (Poole & 
Dell, 2005, National Center on Addiction & Substance Abuse, 2006, Roberts & Vromen, 2005, 
TSA Consultancy, 2005).
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Misuse of drugs can cause both health and social problems, including chronic ill health, 
mental health diﬃculties, and relationship problems, as well as indirect eﬀects on those 
around the user. Although women are generally less likely than men to misuse drugs, the 
impact of drug use on their lives, and particularly on their health, is often disproportionately 
high. One of example of this is provided by research carried out by the Merchants Quay 
Ireland drug treatment service, which found that, in spite of the fact that they had a shorter 
history of drug use and shorter injecting careers, female drug users were more likely 
than their male counterparts to report a range of physical and mental health complaints 
(Cox & Lawless, 2000). Commentators have also suggested that women may progress to 
problematic drug use and dependency more quickly than men (Cox et al., 2008).
4.1. Physical
Women have been found to be particularly vulnerable to the negative physical health 
eﬀects of drug use, even at the generally lower levels of drug misuse which women engage 
in compared to their male counterparts. Researchers have shown that even low levels of 
substance use are associated with more serious health consequences for women and girls 
(Poole & Dell, 2005).
4.1.1. Death
People who misuse drugs are far more likely to die prematurely than their non-drug using 
peers. The EMCDDA has found that mortality among drug users is up to ﬁfty times higher 
than that of the general population (EMCDDA, 2008a). Death can occur as a result of a 
number of causes including overdose, medical consequences of drug use, accidents due to 
being under the inﬂuence of drugs and infections contracted as a result of injecting drugs 
(Long et al., 2005, Cassin & O’Mahony, 2006). The HRB’s National Drug Related Deaths Index 
recorded a total of 2442 drug related deaths during the years 1998 to 2005, of which 1553 
were directly drug related deaths (poisonings) and 889 were indirectly drug-related deaths. 
Women made up 32.9% of deaths by poisoning, and 16.3% of indirectly drug-related deaths 
(Lyons et al., 2008).
As men are more likely to misuse drugs than women, it is unsurprising that most drug-
related deaths in all EU countries are male. Among the EU population aged 15-39 years, 
the average rate of mortality caused by drug overdose in females is about nine per million, 
compared with 48 per million in males (EMCDDA, 2006). In a twenty-year follow up on 
a study of 55 pregnant opiate users in Ireland, Whitty and O’Connor found a particularly 
high mortality rate, with 53% of the women (n=29) deceased. The researchers stated that 
the mortality rate was almost three times that of the general drug using population and 
many times higher that what would be expected in a non-drug using population (Whitty & 
O’Connor, 2007). 
4. Consequences of Drug Misuse for Women
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Opiates are the drugs most likely to be responsible for deaths by poisoning. However, given 
women’s high prescription and use rate, it is essential to note that benzodiazepines, often  
in conjunction with an illicit substance, have been implicated in more deaths than any  
other drug (Lyons et al., 2008).  The National Suicide Research Foundation has stated that 
there is a need to consider restricting the availability of minor tranquilisers, as they are 
involved in more than 40% of intentional drug overdose acts (National Suicide Research 
Foundation, 2008).
4.2.2. Blood-borne viruses
Injecting drug use has been identiﬁed as a major risk factor for blood borne viruses, including 
HIV, in women (Poole & Dell, 2005, Reynolds et al., 2008). This is particularly the case because 
women have been found to be more likely than men to share used injecting equipment 
(Farrell, 2001, Dorman et al., 1997). Women’s risk is also higher, however, because they are 
more likely to have sexual partners who also inject drugs, and often do not use condoms 
with their partners (Dorman et al., 1997). Not practising safe sex is especially dangerous for 
women, since they have a higher risk than men of contracting sexually transmitted infections 
due to their much larger area of mucous membrane (EMCDDA, 2006). Injecting drug use 
has also been linked with involvement in prostitution, something which further increases 
women’s risk of contracting HIV/AIDS and other sexually transmitted infections (EMCDDA, 
2006, Poole & Dell, 2005). Two of the most common blood-borne viruses found among drug 
users are HIV and Hepatitis C. 
HIV
The total number of HIV infections reported in Ireland up to the end of June 2008 is 4,951. 
The latest ﬁgures show that there were 170 newly diagnosed HIV infections reported in 
Ireland during the ﬁrst two quarters of 2008, 38.2% of which were female. For adults, the 
mean age at HIV diagnosis among females was 33.9 years, while it was 37.9 years among 
males. Where the probable route of transmission was known, injecting drug use was 
implicated in 11.8% of cases (Health Protection Surveillance Centre, 2008). The follow-up 
report to a study of pregnant opiate users in Ireland found a high incidence of HIV infection 
and HIV-related mortality; over half the women tested positive for HIV, and 17 of the total 
55 women in the study were found to have died as a result of HIV and complications of the 
disease (Whitty & O’Connor, 2007). 
Hepatitis
The EMCDDA has stated that infectious diseases such as hepatitis A, B and C are an 
important health consequence of drug addiction, particularly where injecting drug use is 
concerned. Hepatitis C is particularly common among Irish injecting drug users (O’Brien 
& Dillon, 2001). It is a blood-borne viral infection that aﬀects the liver; it can cause liver 
failure, cirrhosis and hepatocellular carcinoma, although new drug therapies meant that it 
is now possible to treat disease successfully in many people (Health Protection Surveillance 
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Centre, 2009a). The majority of new cases of the disease are related to injecting drug use 
and to sharing of injecting equipment (EMCDDA, 2004, Reynolds et al., 2008, Healy et al., 
2000), although it may also be passed on through unprotected heterosexual contact with 
an infected partner (Healy et al., 2000). Research has also found that hepatitis C is also 
more common among non-injecting drug users than in the non-drug using population 
(Scheinmann et al., 2007). A high prevalence of hepatitis C has been found among those 
injecting drugs for less than two years in Dublin (53.1%), and among new treatment clients 
84% of injecting drug users tested seropositive for hepatitis C (EMCDDA, 2004). Although 
women accounted for a smaller proportion than men of cases of hepatitis C, it is worth 
noting that on average female cases are younger than their male counterparts (Health 
Protection Surveillance Centre, 2009b).
In order to prevent/minimise the spread of infectious diseases such as hepatitis C and HIV, 
the EMCDDA has recommended harm reduction measures including screening, counselling 
and education, methadone maintenance treatment, and needle and syringe exchange 
programmes (EMCDDA, 2004).
4.2.3. Fertility issues
A woman’s fertility can be aﬀected by drug use, through its aﬀect on her menstrual 
cycle. It has been found that dependence on heroin or other opioid drugs can produce 
amenorrhoea and menstrual irregularity (Bell & Harvey-Dodds, 2008, Whittaker, 2003), and 
smoking marijuana has been associated with disruption of the ovulatory function (Mueller 
et al., 1990). Cocaine use has been associated with infertility caused by tubal abnormalities, 
although the researchers stressed that this area requires further research (Mueller et al., 
1990). Where menstruation is irregular because of drug use, women may be at higher risk 
of unintended pregnancy, and may not be aware that they have become pregnant straight 
away. One study of British female drug users found that almost three-quarters reported 
an unplanned pregnancy (Bell & Harvey-Dodds, 2008). Treatment with methadone or 
buprenorphine for opiate users has been found to reverse the illicit drug eﬀects on the 
menstrual cycle quite quickly, so it is essential to advise women entering treatment of the 
risks of becoming pregnant (Bell & Harvey-Dodds, 2008).
4.2.4. Drug use in pregnancy
Drug misuse during pregnancy is not common. In a study by one of Dublin’s three maternity 
hospitals, only 4.57% of all pregnant women between from 1999-2005 reported having 
used illicit drugs in pregnancy (Barry et al., 2007). The majority of women in the study who 
reported drug use were found to be on methadone, which suggests that most were in 
treatment rather than misusing illicit drugs. This is an important point, as drug problems are 
often associated with a chaotic lifestyle. This can mean that women do not access maternity 
care as soon as is recommended, and that they do not attend antenatal care as often as non-
drug using women (Whittaker, 2003).
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In Scotland, research has shown that the majority (71%) of live babies born to drug misusing 
women were full-term and of normal birth weight (Drug Misuse Information Scotland, 2008). 
However, drug misuse can have serious eﬀects on obstetric and pediatric morbidity and 
mortality. Misuse of drugs in pregnancy has been associated with increased rates of low birth 
weight, pre-term delivery, Sudden Infant Death Syndrome (SIDS) and Neonatal Abstinence 
Syndrome (NAS) (Whittaker, 2003). Low birth weight is the eﬀect common to the misuse 
of most drugs in pregnancy. It has been linked with the use of cannabis (possibly because 
it is smoked in a mixture with tobacco), opioids, and cocaine. Benzodiazepine use may 
increase the risk of cleft palate, reduce brain development and aﬀect long-term outcomes 
for the baby, as well as causing withdrawal symptoms in newborns that can be severe and 
prolonged. Cocaine use is reported to increase the risk of placental abruption, intrauterine 
growth restriction (IUGR), underdevelopment of organs and/or limbs, miscarriage and 
stillbirth, and pre-term delivery. Opiate use is associated with IUGR, pre-term delivery, SIDS 
and most commonly with NAS; abrupt withdrawal of opiates has been associated with 
miscarriage, stillbirth and pre-term labour. The eﬀects of using ecstasy, amphetamines, 
hallucinogens or solvents have not yet been documented to a signiﬁcant extent in the 
literature (Whittaker, 2003).  
Studies in Ireland have conﬁrmed that the babies of drug using women are more likely to be 
delivered prematurely, and to have lower average birth weights (Thornton et al., 1990, Barry 
et al., 2007). In the Coombe Hospital study in Dublin, the highest rates of low birth weight 
were found among the babies of heavy smokers and users of illicit drugs - 16.6% babies of 
drug-using mothers weighed less than 2500g, compared to 5.1% of infants born to mothers 
who reported no illicit drug use during pregnancy (Barry et al., 2007). 
It is important to note that women who misuse drugs during pregnancy may be an 
especially vulnerable group with a multiplicity of needs in many areas. A study of a sample 
of pregnant opiate users in Dublin found that by 20-year follow-up more than half of the 
55 women had died, mainly from HIV related illnesses. The authors stated that the high 
mortality rate demonstrated that these women were a particularly high risk group with poor 
outcomes (Whitty & O’Connor, 2007). It should also be noted that pregnancy outcome is 
the result of many interlinked factors including genetics, physical and psychological health, 
nutrition, health and social care, social deprivation and other environmental inﬂuences as 
well as the eﬀects of drug use (Whittaker, 2003). Commentators have pointed out that many 
of the obstetric problems associated with substance misuse, including low birth weight and 
increased perinatal mortality, are also associated with social deprivation, poor antenatal care, 
and poor maternal health and nutrition (Mounteney, 1999). It is therefore essential to ensure 
that pregnant drug users can access specialised, integrated care services that will take all 
of their needs into account. Pregnancy is often a time of new beginnings for women with 
drug misuse issues, and a prompt that encourages them to tackle their substance use (Cox 
& Whitaker, 2009). Harm reduction approaches, which do not judge women but encourage 
them to reduce their use of drugs, may therefore present the best method for securing a 
healthy outcome for both the woman and her baby. 
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4.2.5. Other
In addition to the physical consequences of drug misuse outlined above, women are also 
at risk of complications from injecting drugs such as abscesses, infections, blood clots, deep 
vein thrombosis, endocarditis, septicaemia and gangrene (which can result in the loss of 
limbs) (Cassin & O’Mahony, 2006, Whittaker, 2003, Merchants Quay Ireland, 2007). One study 
which highlighted women’s vulnerability to these problems was carried out at the Merchants 
Quay Project in Dublin in the late 1990s. It found that women were more likely than men to 
report abscesses, to have problems ﬁnding an intravenous site (suggesting damage to veins), 
and to suﬀer from weight loss (Geoghegan et al., 1999). 
4.2. Mental/Emotional
The United Nations Oﬃce on Drugs and Crime has pointed out that women with substance 
use problems have higher rates than men of concurrent psychiatric disorders, particularly 
post-traumatic stress disorder and other mood and anxiety disorders (UNODC, 2004). 
Research has shown that as many as two-thirds of women with substance misuse problems 
may have a concurrent mental health problem such as depression, post-traumatic stress 
disorder, panic disorder and/or an eating disorder (Cormier et al., 2004). The National Center 
on Addiction and Substance Use in America has noted that stress is a common precursor 
for substance use in women of all ages, and that girls who are susceptible to depression and 
anxiety are at particularly high risk of developing substance use disorders (National Center 
on Addiction & Substance Abuse, 2006). Strong links have been found between drug misuse 
and depression, and it has been suggested that there is a bi-directional relationship between 
the two – i.e., that depression is a reason for, as well as a product of, drug misuse (Needham, 
2007). Women in the general population have been found to be twice as likely as men to 
suﬀer from depression (Women’s Health Council, 2005), and it may therefore be an important 
pathway to substance misuse for them, as well as being a signiﬁcant consequence.
In Ireland, a study of the health status of female drug users found that the majority of 
participants reported that they had at least one psychological health complaint in the three 
months prior to the study, most commonly depression (Lawless, 2003). The Health Research 
Board has noted the particularly high rates of depression among drug users, citing studies 
which have shown that users are at greater risk of suicide than the population who do not 
use drugs (Lyons et al., 2008). This risk may be heightened among women, as research has 
shown that women (80%) are more likely than men (65%) to overdose on drugs as a method 
of deliberate self-harm (National Suicide Research Foundation, 2008). A study of adolescent 
opiate misusers in Ireland revealed that young women were more likely to report past 
suicidal behaviour than their male counterparts (Fagan et al., 2008).
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4.3. Social & interpersonal consequences 
 
  ‘Social exclusion aﬀects more women than men, with female drug users suﬀering from twofold 
discrimination both as drug users and as women (EMCDDA, 2006).
Perhaps because drug misuse is less common among women than men, women who use 
drugs often experience more stigma than do their male counterparts (Poole & Dell, 2005, 
Woods, 1999, Hedrich, 2000, UNODC, 2004). Use of drugs may impact on a woman’s social 
and personal life in diﬀerent ways to those of a male drug user. For example, the stigma 
attached to drug misuse can have implications for a woman’s housing situation. Drug 
use (classed as ‘antisocial behaviour’) can be a reason for a woman being asked to vacate 
public housing; private landlords are selective about tenants and often drug users and 
women with children are not welcome; and many homeless shelters prefer not to provide 
accommodation for drug users because of their unpredictable, chaotic behaviour (O’Neill & 
O’Connor, 1999, Woods, 1999). Similarly, women as the partners of drug users may also face 
stigma and diﬃculties in accessing housing. 
In addition, women’s drug misuse may have wider social and interpersonal consequences for 
their families, and particularly for their children. In Irish society women still form the majority 
of primary carers for children and older relatives (Women’s Health Council, 2003, Women’s 
Health Council, 2007, Women’s Health Council, 2002). The chaotic lifestyle associated with 
drug misuse may mean that women are not present to play this key role in supporting and 
caring for the family. Research has found that the children of mothers with substance misuse 
problems are less likely to remain with their birth mother, more likely to show developmental 
delay, and are signiﬁcantly more at risk of abuse and neglect than the general population 
(Keen et al., 2000). As a group, the children of drug misusing parents also perform less well 
academically and in terms of social adjustment (Keen & Alison, 2001).  
 ‘ Taken overall, there can be no doubt that parental drug misuse is a very important factor in 
preventing many children from achieving physical, mental and emotional health’  
(Keen & Alison, 2001). 
Parental misuse of drugs can also be an important inﬂuence on children’s behaviour around 
drugs. Children have been found to be more likely to misuse drugs in situations where their 
parents misuse drugs, where there is prolonged or traumatic parental absence, failure to 
communicate on an emotional level, and chaotic or disturbed family members (UNODC, 
1995). The latest ESPAD report for Ireland found that while emotional support and care from 
parents inﬂuences children’s substance (mis)use, parental monitoring, where children felt 
that their parents were ‘keeping an eye’ on their activities, was more important still (Morgan 
& Brand, 2009). If the parents themselves are misusing drugs, this monitoring is less likely 
to occur. It is important to note, however, that there is much evidence to suggest that 
interventions aimed at treating parental drug problems can have a stabilising inﬂuence  
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on the user herself, and this can in turn improve family functioning (Keen & Alison, 2001).  
The particular needs of women around treatment for drug misuse will be discussed  
further below.  
In addition to the eﬀects of drug misuse on the woman’s family, it can have other social 
and interpersonal on the woman’s own life. In particular, drug misuse also leaves women 
vulnerable to exploitation and victimisation, as described below.
4.3.1. Prostitution
Prostitution seems to be both a consequence of and a pathway into drug misuse for women. 
The EMCDDA has pointed out that female drug users, particularly those on heroin, are often 
involved in prostitution, but it is not always clear drug use leads to prostitution or vice versa 
(EMCDDA, 2006). Some commentators have speculated that the high price of illicit drugs 
encourages some drug users into providing sex for money or sex for drugs to support their 
habit (Cassin & O’Mahony, 2006, Woods, 1999). Research carried out in Ireland has found 
that the majority of women drug users working in prostitution report becoming involved 
for economic reasons, in order to ‘make money for drugs’ (Cox & Whitaker, 2009, O’Neill 
& O’Connor, 1999). Research has also found that female drug users in prostitution were 
younger, neglected their health more and were less likely to use medical services than non-
drug using women working in prostitution; overall, the researchers described women drug 
users working in prostitution as ‘a marginalised group within a marginalised group’ (O’Neill & 
O’Connor, 1999).  Research has also identiﬁed drug and alcohol use as a survival mechanism 
for women working in prostitution. An Irish study found that women reported habitually 
getting drunk or stoned or using prescription drugs in order to work, using drugs and 
alcohol to numb the pain of prostitution (TSA Consultancy, 2005). Recent research published 
by the NACD found that although women’s drug use enabled them to minimize the distress 
associated with the work and to work longer hours, working while ‘stoned’ increased the risk 
of engaging in unprotected sex and of being unable to assess the potential dangers of a 
situation (Cox & Whitaker, 2009). 
4.3.2. Vulnerability to assault/victimisation
High rates of victimisation have been found among substance misusing women (Cormier 
et al., 2004). The EMCDDA has pointed out that drug-facilitated sexual assaults are most 
easily perpetrated against women whose drug and alcohol use make them particularly 
vulnerable (EMCDDA, 2008b). The use of central nervous system depressants, in particular, 
has been linked with vulnerability to sexual assault; this category of drugs includes alcohol 
and benzodiazepines (such as ﬂunitrazepam or Rohypnol). However, recreational drugs 
such as ecstasy, amphetamine, cocaine and ketamine can also be disinhibiting and if taken 
with alcohol can cause drowsiness and loss of consciousness which can leave women in 
a vulnerable position (EMCDDA, 2008b). In any discussion of sexual assault, however, it 
is crucial to note that while substance misuse can increase a woman’s vulnerability, this 
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should not deﬂect attention or blame from the perpetrator, suggest that the perpetrator’s 
responsibility for the assault is reduced in any way, or suggest that the woman is somehow 
to blame for the attack. 
4.4.  Eﬀects of others’ drug misuse on women –  
the burden of care
As the Women’s Health Council pointed out in Promoting women’s health; A population 
investment for Ireland’s future, although more women are now taking part in the paid labour 
force, women are still primarily responsible for providing care to the members of their 
families and others in their communities (Women’s Health Council, 2002). This means that, 
for the most part, it is women who assume responsibility for the care and management 
of substance misusers in the family. This can place women at risk of violent and abusive 
behaviours, and it can also mean that they have to assume sole ﬁnancial responsibility for 
the family. The negative implications for the physical and mental health of women in these 
situations are clear. 
A study of workers in the drug treatment and social work ﬁelds in Dublin highlighted 
the fact that when there is a need to ﬁnd alternative care arrangements or support for a 
woman drug user or her children, it is other women within the kinship system – aunts, 
sisters, mothers and grandmothers – who are called upon (Woods, 1999). The same holds 
true for male drug users; the vast majority of those interviewed for NACD’s research on the 
experiences of families seeking support in coping with heroin use were parents, speciﬁcally 
drug users’ mothers (Duggan, 2007). Thus when the Government noted in the National 
Drugs Strategy 2001-2008 that the families of problem drug users ‘have the potential to be 
key to the rehabilitative eﬀort’, and are ‘a valuable resource in terms of childcare’ (Department 
of Community Rural and Gaeltacht Aﬀairs, 2007), the gender dimension of these policy 
statements should be highlighted. In practice, it is usually the drug user’s mother, wife, 
girlfriend, sister, aunt, or grandmother who will provide this care and support, in most cases 
at some cost to her own health and well-being.
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4.5. Drug related crime
The EMCDDA has found that in most countries, women commit between 9% and 15% of 
drug law oﬀences and that they make up between 2% and 8% of the prison population 
of Europe (EMCDDA, 2006). In 2004, 6757 people were prosecuted for drug oﬀences in 
Ireland, of whom 500 (7.4%) were women (Connolly, 2006). The overall number of women 
prosecuted for drug oﬀences each year has remained stable since 1998. 
Crime and drug use are inextricably linked. An early study of Irish drug users found that 51% 
of the sample had been convicted of a crime, with drug-related non-violent crimes (e.g. 
stealing, housebreaking, vandalism, forging cheques, obtaining things by false pretences) 
contributing most to the increase in criminality subsequent to drug misuse (Carr et al., 1980). 
Similarly to British research which found that women prisoners and ex-prisoners most often 
reported becoming involved in crime to fund a drug habit (Roberts & Vromen, 2005), an 
exploratory study of drug use among Irish prisoners found that women were more likely to 
have become involved in crime after they started misusing drugs (Dillon, 2001). Men in the 
same study were more likely to have been involved in crime prior to their drug use. 
The types of crime drug misusing women become involved in are often diﬀerent to those 
of their male counterparts. The ROSIE study found that among its participants, women 
were more likely than men to have committed an acquisitive crime (e.g. shoplifting), while 
men were more likely to be involved in drug dealing (Cox et al., 2008). A study of women 
on remand in the Dochas Centre in Mountjoy Prison, Dublin, found that the most common 
crimes committed by women were drug possession, theft from a shop and handling stolen 
goods (Comiskey et al., 2006). In a related dimension, a study of the prison population of 
Ireland published in 2000 found that 51% of male and 69% of female prisoners reported 
being under the inﬂuence of drugs when they committed the oﬀence for which they were 
serving a sentence (Hannon et al., 2000).
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5.1. Accessing treatment
There are a number of interesting diﬀerences between men and women accessing drug 
treatment services. Women do not misuse drugs at the same rate as men, but it has been 
found that they present for treatment earlier than their male counterparts (O’Brien & 
Dillon, 2001). Among users of opiates, it has been found that women request treatment 
one and a half to two years earlier in their drug career than men (EMCDDA, 2006), and 
that women overall tend to present for treatment at a younger age than men (O’Brien & 
Dillon, 2001, Geoghegan et al., 1999). European ﬁgures have shown that new female clients 
needing treatment for opioids and cocaine use are on average two years younger, and for 
stimulants are four years younger than their male counterparts. The reasons for this are not 
completely clear, but it might be that women progress more rapidly to a level of problems 
with drugs that lead them to treatment or that they are directed to treatment by their 
social environment more rapidly than males (EMCDDA, 2006, Cox et al., 2008). It should be 
noted, however, that male and female clients generally access treatment for cannabis use at 
roughly the same age, and women requesting treatment for the use of hypnotics, sedatives 
or hallucinogens tend to be on average older than their male counterparts (EMCDDA, 2006), 
perhaps reﬂecting the overall age-related trends for use of these drugs.
One further noteworthy gender diﬀerence in use of drug treatment services is the ﬁnding 
that men are more likely to have been sent for treatment by police and the criminal justice 
system than women (22.2% of males vs. 10.6% of females). Women are more likely to have 
accessed treatment through health and social services - 36% of females seek treatment 
through health or social services, general practitioners or other drug treatment centres 
compared to 27% of males (EMCDDA, 2006). 
5.2. Treatment options
Treatment for drug misuse in Ireland is provided by both statutory and non-statutory 
services, and in a range of settings including residential centres, community-based addiction 
services, GP services and within prisons. Public clinics are usually based in community health 
centres or local health oﬃces, and addiction counselling is oﬀered in many day hospitals. 
Community care services also oﬀer therapy for families, couples and groups, as well as the 
individuals aﬀected. Private treatment services, run by charities and private limitd companies, 
are also available. Referrals to most residential programmes can come from a doctor, social 
worker, the courts and probation services, community nurses or workplaces, and costs for 
some private programmes are covered by the GMS or social welfare payments. 
Although some services exist which provide treatment for drug misuse alone, for the most 
part treatment services deal with both alcohol and drug misuse (Health Promotion Unit, 
2006). This is particularly the case in areas outside Dublin (Carew et al., 2009) where services 
are more likely to be integrated. Within Dublin, services are slightly more fragmented with 
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a small proportion of services oﬀering treatment for alcohol alone or drug misuse alone, 
although a few services oﬀer treatment for the misuse of alcohol and/or prescription drugs. 
There is a wide variation in the numbers and types of treatment services across the country, 
with the greatest concentration of services in Dublin, as might be expected given its greater 
population density. A directory of drug and alcohol services published by the Health 
Promotion Unit in 2006 listed forty-two drug and alcohol treatment services for Dublin 
(not including HSE satellite clincs), whereas there were no dedicated services available in 
Leitrim (clients had to travel to Sligo town), Oﬀaly (travel to Port Laoise) or Cavan (travel to 
Monaghan or Sligo) (Health Promotion Unit, 2006). 
A four tier model of drug treatment service provision was recommended by the Working 
Group on Treatment of under 18-year-olds presenting to Treatment Services with Serious 
Drug Problems (Department of Health & Children & HSE, 2005), and was also endorsed to 
by the HSE Working Group on Residential Treatment & Rehabilitation (Corrigan & O’Gorman, 
2007). Under this model, tier one services are aimed at those starting to experiment with 
drugs or alcohol and consist of drug-related information and advice, screening and referral 
to specialised drug treatment services. They are provided in general healthcare settings, 
education, social care or in criminal justice settings. Tier two services are provided for people 
with problems resulting from drug or alcohol misuse and include drug-related prevention, 
brief intervention, counselling, and harm reduction delivered through outreach, primary 
care, pharmacies, criminal justice settings, and community- or hospital-based specialist drug 
treatment services. Tier three services are for those experiencing substantial problems as a 
result of drug or alcohol use and are mainly delivered in specialised structured community 
addiction services as above, as well as in primary care settings such as Level 1 or Level 
2 GPs, pharmacies, prisons, and the probation service. Services consist of community 
based specialised drug assessment and coordinated, care-planned treatment including 
psychotherapeutic interventions, methadone maintenance, detoxiﬁcation and day care. 
Finally, tier four services, for those experiencing severe problems as a result of drug or 
alcohol misuse, consist of intensive interventions through day or inpatient hospitals, 
including residential specialised drug treatment in dedicated inpatient or residential units/
wards, or in general psychiatric wards. Continuity of care and aftercare is important and it 
is recommended that treatment services be linked to residential rehabilitation units and 
halfway house accommodation (Corrigan & O’Gorman, 2007)3. 
According to oﬃcial ﬁgures, the majority of the 68,754 cases treated between 2001 and 
2006 attended outpatient services (68%) (Reynolds et al., 2008). Gender diﬀerences have 
been noted in the setting for drug treatment; men are more likely to receive treatment 
at residential or low-threshold services, while women are more likely to present to non-
residential or GP services for treatment (O’Brien & Dillon, 2001)4. This may be partly due to the 
3  Personal communication from Ms Alice O’Flynn, Care Group Manager—Social Inclusion, HSE, 20th April 2009.
4  It should be noted that the response to people who misuse drugs by GPs/primary care teams will be similar to that of any 
other primary care patient; they will be treated on an equal footing and not segregated or discriminated against in any way.
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fact that residential services are generally more focused towards men (Corrigan & O’Gorman, 
2007). Currently there is only one residential treatment centre in Ireland that incorporates 
childcare facilities. Ashleigh House, run by the Coolmine Therapeutic Community, is a 
residential rehabilitation service for women that oﬀers ‘family places’ for children, and 
includes a qualiﬁed childcare worker on staﬀ, play areas for children, and parenting support. 
It was successfully piloted in 2008, and at the time of writing had one woman and her pre-
school child in treatment.5 However, women may also have a preference for treatment in 
non-residential settings due to their childcare responsibilities; female drug treatment clients 
are far more likely to be living with children than their male counterparts (EMCDDA, 2005).
Drug treatment options include medication (detoxiﬁcation, methadone reduction, 
substitution programmes and psychiatric treatment), brief intervention, counselling, group 
therapy, family therapy, psychotherapy, complementary therapy, and/or life-skills training 
(Department of Community Rural and Gaeltacht Aﬀairs, 2007, Reynolds et al., 2008). A 
combination of methods is usually used as the most eﬀective way to treat drug misuse. 
In 2006, 51% of people entering treatment for problem drug use received counselling, 
39% received methadone substitution, 17% received a brief intervention, 14% attended 
medication-free therapy and 36% received more than one initial treatment intervention 
(Reynolds et al., 2008). 
5.3. Particular needs of women
 
  …sex diﬀerences and gender inﬂuences aﬀect women’s and men’s use of and response to 
substance use, and their treatment needs are correspondingly diﬀerent (Poole & Dell, 2005).
In their study of adolescent opiate users, Fagan et al noted that complete abstinence may 
not be the sole aim; rather users may be ‘seeking relief from the overall chaos and  
instability in their lives’ (2008:50). The same may be true for women who misuse drugs; 
therefore it is useful to note that the researchers recommended that treatment services be 
ﬂexible and multidisciplinary in nature, and that they should be able to use a range of bio-
psycho-social interventions to help treat and stabilize drug users (Fagan et al., 2008). Since 
women and men can have quite diﬀerent experiences and issues around drug misuse, a 
gendered approach to treatment must be adopted so that women’s and men’s needs are 
dealt with in the most appropriate manner possible. As emotional and relational reasons are 
often at the crux of women’s misuse of drugs, services for women may require an increased  
emphasis on care and support (Poole & Dell, 2005, National Center on Addiction & Substance 
Abuse, 2003).
5   Personal communication from Mr. David Madden, Manager of Coolmine Therapeutic Community Ashleigh House,  
23rd April 2009.
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An important issue that has been identiﬁed regarding treatment services for women is the 
fragmented nature of service provision. The need for integrated services during pregnancy 
has already been mentioned above, but this holds true for all drug misusing women, who 
often have a multiplicity of needs rather than just one problem. Drug using women  
working in prostitution, for example, have been found to ‘move more or less continuously 
through social, mental health and healthcare agencies, homeless hostels, drug and alcohol 
services and the prison system’ (Cox & Whitaker, 2009). Research has concluded that, in  
order to prevent women being lost through loopholes in the system, there is a need for 
greater co-operation, collaboration and communication between agencies providing 
services (Comiskey et al., 2006). Treatment programmes often do not provide women 
who misuse drugs with the full range of services they may need, including prenatal and 
gynecological care, contraceptive counselling, childcare, job training, advice and support 
around housing, and counselling for sexual and physical abuse. Given the chaotic nature of 
the lives of those misusing drugs, and the problems this creates around connecting with 
services, it is important that services are co-ordinated to avoid presenting women with a 
confusing array of appointments and services and losing them from the system entirely 
(Keen & Alison, 2001). 
In providing services, greater awareness is needed of the gender-speciﬁc issues that can 
lead to substance misuse, and it is essential that a gendered approach is taken in all services 
provided. Staﬀ must be aware of the particular pathways and background factors that 
lead to women misusing drugs, so that their needs can be fully addressed. In some cases 
providing female counsellors and other workers may be helpful as many women substance 
users have previously experienced problems with men (Painter et al., 2000, UNODC, 2004). 
Support groups and one-to-one counselling have also been suggested as methods which 
particularly appeal to women and encourage them to attend treatment services (Farrell, 
2001, EMCDDA, 2006).
Two areas have been identiﬁed as being particularly important in ensuring that women’s 
needs are adequately provided for by treatment services.
5.3.1. Childcare
Research has found that entering treatment may be more problematic for drug using 
women than for men. This is both because women often experience a greater stigma 
attached to their drug use, but also because women are more often responsible for children 
than their male counterparts (Poole & Dell, 2005, EMCDDA, 2005, EMCDDA, 2006, Painter et 
al., 2000, Cox et al., 2008). In Ireland, women users are more likely to be lone parents (Farrell, 
2001). A study of workers in the drug treatment and social work ﬁelds in Dublin found that 
those interviewed said that it was rare to meet a woman drug user who was not a mother 
– the vast majority female drug users accessing social work and drug treatment services had 
children (Woods, 1999). 
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Being responsible for children can mean that it is diﬃcult for women to attend for treatment 
(UNODC, 2004). Studies in Ireland have found that while parents (mostly women) often 
wanted to take active steps to address their drug use, they were unable to do so as they did 
not have access to regular childminding arrangements (Moran, 1999, Butler & Woods, 1992). 
Women may also be reluctant to attend for treatment as they fear that their drug misuse 
may cause them to be labelled ‘unﬁt mothers’ and that their children will be taken into care 
as a result (Butler & Woods, 1992, Farrell, 2001, Bell & Harvey-Dodds, 2008, Painter et al., 2000, 
Hedrich, 2000, UNODC, 2004).
However, it has also been suggested that having children, and particularly becoming 
pregnant, may be an important reason that women decide to attend for treatment 
(Bell & Harvey-Dodds, 2008, Whittaker, 2003, EMCDDA, 2006). It is therefore extremely 
important that treatment services are made accessible to women by taking their childcare 
needs into account. Crèche facilities are essential, as they encourage women to attend 
for treatment by providing for women’s practical childcare needs, but also by signalling 
the service’s acceptance of women’s situations (Moran, 1999). Both drop-in and full-day 
crèches are needed so that women can participate in all types of treatment (including more 
intensive treatment and rehabilitation) and to facilitate access to training and employment 
opportunities (Moran, 1999, Woods, 1999). 
Action 54 of the National Drugs Strategy called on the Health Service Executive to consider, 
as a matter of priority, how best to integrate childcare facilities with treatment and 
rehabilitation centres and how childcare can best be provided in a residential treatment 
setting (Department of Tourism Sport & Recreation, 2001). In addition, the Working Group 
on Drugs Rehabilitation identiﬁed the lack of childcare services as a signiﬁcant barrier 
to accessing treatment for women and reported that drugs-related services, including 
residential services, should have access to an appropriate level of childcare services and 
facilities. It therefore recommended that the HSE, in conjunction with the Oﬃce of the 
Minister for Children, should decide on how best to integrate childcare facilities with 
treatment and rehabilitation services and subsequently progress the matter (Department 
of Community Rural and Gaeltacht Aﬀairs, 2007). The report of the HSE Working Group 
on Residential Treatment & Rehabilitation did not refer to providing childcare as part of 
rehabilitation services; it recommended the investigation of “innovative approaches such 
as providing the necessary supports so that family members can act as short-term foster 
parents” (Corrigan & O’Gorman, 2007). 
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5.3.2. Pregnant drug users
Across Europe, pregnant drug users are deﬁned as a priority group and are given preferential 
access to drug treatment (EMCDDA, 2006). However, chaotic lifestyle and fear of stigma can 
often mean that these women do not attend for antenatal care as frequently or as early as is 
recommended. For these and related reasons, a specialist Drug Liaison Midwife (DLM) service 
was established in 1999 in Ireland, to liaise between the three Dublin maternity hospitals 
and drug treatment services (Scully et al., 2004, Scully et al., 2001). The DLM provides support 
to the women around their drug use and their general health, and can refer women to 
social services, local genito-urinary infectious diseases clinic or hepatology clinic, if they are 
HIV or Hepatitis C positive. In 2007, a total of 96 women were referred to the HSE Dublin 
Mid-Leinster Drug Liaison Midwife (Coombe Women & Infants University Hospital, 2008). 
Seventy-eight of these women delivered 79 babies (one set of twins) in the Coombe Women 
& Infants University Hospital, of whom 76 were live births. Of the 76 live babies, 46% had to 
be admitted to the Special Care Baby Unit and 30% needed treatment for NAS (neonatal 
abstinence syndrome). 36% of the women attending the Drug Liaison Midwife were 
Hepatitis C positive and 8% were HIV positive, with one new diagnosis made from booking 
bloods. The Drug Liaison Midwife service was found to help lessen the stigma for drug-
misusing women, and improved the relationships between the women and the obstetric 
and drug services (Scully et al., 2004, Scully et al., 2001). However, it is important to highlight 
that the services provided to pregnant drug misusers often do not continue beyond the 
birth, eﬀectively leaving such women, who may be in a heightened state of vulnerability 
after the birth, and their babies without specialist support (Keen & Alison, 2001). Services 
to drug misusing mothers need to be continued beyond birth to ensure the best possible 
outcome for both the mother and her child(ren).
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6.1. Drug misuse strategy
Ireland’s most recent national strategy on drugs, Building on experience: National Drugs 
Strategy 2001-2008, was published in 2001 by the Department of Tourism, Sport and 
Recreation. The Department of Community, Rural and Gaeltacht Aﬀairs currently has 
responsibility for co-ordinating the implementation of the National Drugs Strategy, and a 
number of structures also exist to implement and deliver the National Drugs Strategy. These 
are the National Advisory Committee on Drugs (NACD); the National Drugs Strategy Team, 
made up of members from government departments and agencies involved in the drugs 
ﬁeld as well as representatives from the community and voluntary sectors; the Regional 
Drugs Task Force; and the Local Drugs Task Forces. 
Four areas were highlighted in the Strategy as being crucial in any attempt to address the 
problem of drug misuse:
 1.   Reduction in the supply of drugs. The main work in this area is carried out by the 
Department of Justice, Equality & Law Reform, the Gardaí, the courts, the prisons 
service, and the Probation and Welfare services. A Dial to Stop Drug Dealing scheme 
has also been developed, to provide a conﬁdential and anonymous way for people 
to pass on information on drug dealing in their community.
 2.   Prevention of drug use. This heading covers education and awareness programmes 
provided by the Health Promotion Unit of the Department of Health & Children, 
awareness and education programmes run in schools by the Department of 
Education and Science, and education programmes run by the Gardaí and Local 
Drugs Task Forces in schools and the community.
 3.  Drug treatment, covering rehabilitation and risk reduction. Addiction counselling, 
detoxiﬁcation programmes and methadone treatment programmes are essential 
components of this area, as well as the services provided in prisons for drug 
misusers. Fas also runs programmes aimed at helping reformed drug users get back 
into the workforce. 
 4.  Research. As included above, the NACD produces a variety of research on the area 
and advises the the government on drugs policy issues, while the Alcohol and Drug 
Research Unit of the HRB oversees the National Drug Treatment Reporting System 
and National Drug Related Deaths Index, and also produces a range of research on 
drug use and drug-related issues.
Several documents have been produced since the Strategy was published, including a report 
on implementing the Strategy (Department of Community Rural and Gaeltacht Aﬀairs, 2004), 
a progress report (Department of Community Rural and Gaeltacht Aﬀairs, 2005b), a mid-term 
review which looked at progress and added eight new actions (Department of Community 
Rural and Gaeltacht Aﬀairs, 2005a), and a report examining the area of rehabilitation carried 
out under the auspices of the Strategy (Department of Community Rural and Gaeltacht 
Aﬀairs, 2007). 
6. Drug Misuse Strategy & Legislation  
in Ireland 
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An important point to note about the Strategy is that, unlike its predecessors, it focused 
exclusively on ‘problem drugs’ – opiates – and did not address substances such as 
alcohol, prescription drugs and over-the-counter drugs (Pike, 2008). This meant that its 
recommendations, in common with those in the second report of the Ministerial Task 
Force on Measures to Reduce the Demand for Drugs, focused on young people living in 
disadvantaged areas and groups vulnerable to drug misuse such as prisoners (Ministerial Task 
Force, 1997). Viewed through a gendered lens, this approach gives rise to obvious concerns 
for women, as it eﬀectively ignores areas where women’s drug misuse has been found to be 
higher than men’s. 
A wide-ranging consultation process on the National Drugs Strategy 2009-2016 was held 
during 2008, and the new strategy is due to be published in 20096.
6.2. Drug misuse legislation
The main legislation for bringing criminal charges for drugs oﬀences is the Misuse of 
Drugs Act 1977 and the Misuse of Drugs Act 1984 (Citizens Information, 2008). These were 
introduced in direct response to the rising level of opiate use - Dublin’s ‘opiate epidemic’ 
– in the late 1970s and early 1980s (Dean et al., 1987).  Together with the Misuse of Drugs 
Regulations 1988, the legislation puts controls on cultivation, licensing, possession, 
administration, supply, record-keeping, prescription-writing, destruction and safe custody 
of drugs (European Legal Database on Drugs, 2004). The Misuse of Drugs Acts have been 
further added to and amended by the Criminal Justice Acts 1984, 1996, 1999, 2006 and 2007. 
The main drug oﬀences under which criminal charges are brought are possession of 
controlled drugs, and possession of controlled drugs for the purposes of supply. It is also 
illegal to grow cannabis plants or opium poppies, to forge or fraudulently alter a prescription, 
and to attempt to commit an oﬀence covered by the legislation or to help someone else 
commit an oﬀence. It is also illegal to occupy or control any land, vehicle or vessel which is 
used for activities such as the manufacture, importation or supply of a controlled drug. 
The penalities for drugs oﬀences most commonly consist of ﬁnes and/or imprisonment, with 
the size of the ﬁne and length of sentence related to the severity of the oﬀence. In some 
cases, however, rather than imposing a prison sentence or ﬁne, the Court can order a person 
to undergo treatment for drug misuse, and can also order him/her to complete an education 
or training course to improve job prospects, facilitate social rehabilitation or reduce the 
likelihood of him/her committing further drugs oﬀences. It can also order a person to be 
detained in a specialised custodial treatment centre (Citizens Information, 2008).
6   Personal communication, Department of Health & Children, 06.04.09.
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It is clear from the research that drug misuse is an issue for women, albeit in diﬀerent 
ways and for a smaller proportion of women compared to men. Although, as for alcohol, 
the gender gap may be closing for younger women, research indicates that overall 
women have diﬀerent patterns of drug misuse than men - of particular note here is the 
concentration of women among misusers of prescription drugs. Women’s pathways into 
drug misuse are also distinct from those of men, and their social circumstances appear to be 
particularly disadvantaged when compared to those of their male counterparts. For these 
reasons, the Council has put forward the following recommendations regarding women 
and drug misuse. 
7.1. Gender sensitive policy
  ‘It is now accepted that understanding gender diﬀerences in drug-related behaviours is a 
critical requirement for developing eﬀective responses’ (EMCDDA, 2006:21)
After examining the research, the Women’s Health Council has concluded that any policy 
or strategy being developed in the area of drug misuse must pay attention to gender. It is 
clear that drug misuse aﬀects women and men in distinct ways. A gendered policy/strategy 
response is therefore essential in order to address the gender diﬀerences in patterns, types 
and pathways into of drug misuse. In addition, in order to fully address the circumstances of 
drug misuse among women, it is essential that the misuse of prescription drugs is included 
in policy/strategy, and that prescribing patterns are also reviewed in this regard. When 
making recommendations around treatment and rehabilitation, the gender dimension 
of caring for drug users – particularly where it is proposed to use drug users’ families in 
the rehabilitation eﬀort  - should be recognised. Given the increasing polysubstance 
use problems coming to light, the WHC supports the recent decision by Government to 
integrate alcohol and drug misuse in a single policy/strategy on substance misuse.
Recommendation 1: The Women’s Health Council recommends that gender should 
be integrated into the core of any new National Drugs or Substance Misuse Strategy 
being developed.
7.2. Improving women’s access to services
Research has indicated that women who misuse drugs experience particular barriers to 
accessing treatment, central to which is childcare. Women are more likely to be the primary 
carers for children than their male counterparts and therefore often prioritise their children’s 
care over their own need for treatment. Women are also more likely to be in a long-term 
relationship with a drug user than their male counterparts, which may meant that they 
lack partner support for presenting to and remaining in treatment (Hedrich, 2000). The 
7. Conclusions/Recommendations
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increased stigma attached to being a woman and misusing drugs is also an important factor 
to consider, particularly where women fear that their children will be taken away if drug 
misuse is disclosed. It has been found that crèche facilities encourage women to attend for 
treatment, both by providing for women’s practical childcare needs, but also by signalling 
services acceptance of women’s situations (Moran, 1999). It is therefore extremely important 
that drugs-related services, including residential services, should have access to childcare 
services and facilities. 
Recommendation 2: The Women’s Health Council recommends that, in line with the 
recommendations made in the National Drugs Strategy 2001-2008 and the Report of 
the Working Group on Drugs Rehabilitation, the HSE should develop and implement a 
strategy to provide childcare facilities as part of treatment and rehabilitation services 
as a matter of priority. 
An important issue that has been identiﬁed regarding treatment services for women is the 
fragmented nature of service provision. Given the chaotic nature of the lives of those with 
substance misuse issues, and the problems this creates around connecting with services, 
it is important that services are co-ordinated to avoid presenting women with a confusing 
array of appointments and services and losing them from the system entirely (Keen & Alison, 
2001). Although the need for integrated services during pregnancy has been highlighted, 
the same need holds true for all substance-misusing women. In this regard, it is important 
to note that the services provided to pregnant drug misusers often do not continue 
beyond the birth, eﬀectively leaving such women, who may be in a heightened state of 
vulnerability after the birth, and their babies without specialist support. Services to drug 
misusing mothers need to be continued beyond birth to ensure the best possible outcome 
for both the mother and her child(ren).  In addition, in order to prevent women being lost 
through loopholes in the system, there is a need for greater co-operation, collaboration and 
communication between agencies providing services (Comiskey et al., 2006). 
In designing services for substance misusers, it is important to note that women’s needs may 
be quite diﬀerent to men’s, and as such services may need to respond diﬀerently to both. As 
emotional and relational reasons are often at the crux of women’s misuse of drugs and/or 
alcohol, services for women may require an increased emphasis on care and support (Poole 
& Dell, 2005, National Center on Addiction & Substance Abuse, 2003). Female support groups 
and one-to-one counselling have been suggested as methods of encouraging women to 
attend treatment services (Farrell, 2001, EMCDDA, 2006), and providing female counsellors 
and other workers may also be helpful as many women substance users have previously 
experienced problems with men including sexual abuse and violence (Painter et al., 2000, 
UNODC, 2004). 
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Recommendation 3: The Women’s Health Council recommends the development and 
implementation of integrated substance misuse treatment and support services that 
take gender into account.
7.3. Area of particular concern: Prescription drug misuse
Given the higher rate at which women both use and are prescribed tranquillisers or sedatives 
and anti-depressants in Ireland, it is essential that women are fully informed about the 
properties of the drugs and their potential negative eﬀects. It is particularly important that 
women are made aware of the fact that benzodiazepines, often in conjunction with an illicit 
substance, have been implicated in more deaths than any other drug. In November 2008, 
the HSE ran a health promotion campaign to mark European Antibiotic Awareness Day, to 
emphasise the importance of taking antibiotics only when they are really needed. A similar 
campaign should be developed to address prescription rates to and use of tranquillisers or 
sedatives, and anti-depressants among women. 
Recommendation 4: The Women’s Health Council recommends that a health 
campaign should be developed and run to address rates of prescription and use of 
prescription drugs (tranquillisers/sedatives and anti-depressants) among women.
Much research has already been carried out in Ireland covering the area of drug misuse, 
particularly by the HRB and the NACD, and all data currently being recorded by the HRB and 
NACD is disaggregated by gender. However, more research is needed on the area of misuse 
of prescription drugs in order to fully understand women’s drug misuse. Although the NACD 
has recently published data on the prevalence of tranquilliser/sedative/anti-depressant 
use in Ireland, it would be useful to set such ﬁgures in the context of women’s lives, and to 
examine prescribing patterns for these drugs. 
Recommendation 5: The Women’s Health Council recommends conducting detailed 
gender speciﬁc research on the prescribing and use of prescription drugs such as 
tranquillisers/sedatives and anti-depressants in Ireland.
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7.4. Health Promotion
The Women’s Health Council believes it is essential that women are educated about the 
gender diﬀerences associated with drug misuse use, particularly the ﬁnding that women 
are susceptible to more negative health consequences at lower levels of drug misuse than 
men. Such education should also include information on the eﬀects of drug use during 
pregnancy. Education initiatives should be targeted at school aged children and young 
women, as age of initiation can be key in determining the outcomes for women’s lives 
and health. It is also important that parents are educated and aware about the particularly 
important role they can play in inﬂuencing their daughters’ behaviour around drugs and 
alcohol. Innovative approaches to conveying the information to adults will need to be 
developed, perhaps in community settings.
Recommendation 6: The Women’s Health Council recommends that education on 
the particular eﬀects of drug misuse for women should be included in the SPHE 
programme, as well as in education programmes for community settings.  
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